These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3364952

  • 1. C31G, a new agent for oral use with potent antimicrobial and antiadherence properties.
    Corner AM, Dolan MM, Yankell SL, Malamud D.
    Antimicrob Agents Chemother; 1988 Mar; 32(3):350-3. PubMed ID: 3364952
    [Abstract] [Full Text] [Related]

  • 2. Clinical study of a C31G containing mouthrinse: effect on salivary microorganisms.
    Corner AM, Brightman VJ, Cooper S, Yankell SL, Malamud D.
    J Clin Dent; 1990 Mar; 2(2):34-8. PubMed ID: 2090157
    [Abstract] [Full Text] [Related]

  • 3. Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G).
    Caliş S, Sumnu M, Hincal AA.
    Pharmazie; 1994 May; 49(5):336-9. PubMed ID: 8016179
    [Abstract] [Full Text] [Related]

  • 4. A non-antibiotic antimicrobial mixture (C31G): evaluation of the antimicrobial efficiency of C31G on vaginal cultures.
    Calis S, Yulug N, Sumnu M, Ayhan A, Hincal AA.
    Boll Chim Farm; 1992 Oct; 131(9):335-8. PubMed ID: 1492969
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A phase I comparative postcoital testing study of three concentrations of C31G.
    Mauck CK, Creinin MD, Barnhart KT, Ballagh SA, Archer DF, Callahan MM, Schmitz SW, Bax R.
    Contraception; 2004 Sep; 70(3):227-31. PubMed ID: 15325892
    [Abstract] [Full Text] [Related]

  • 13. Prolonged exposure to the candidate microbicide C31G differentially reduces cellular sensitivity to agent re-exposure.
    Catalone BJ, Ferguson ML, Miller SR, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B.
    Biomed Pharmacother; 2005 Sep; 59(8):460-8. PubMed ID: 16154719
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the anti-microbial agent C31G as a spermicide: comparison with nonoxynol-9.
    Thompson KA, Malamud D, Storey BT.
    Contraception; 1996 May; 53(5):313-8. PubMed ID: 8724622
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes.
    Krebs FC, Miller SR, Catalone BJ, Welsh PA, Malamud D, Howett MK, Wigdahl B.
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1954-60. PubMed ID: 10858360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mice and rabbit models for oral and percutaneous absorption and disposition of amphoteric surfactant C31G.
    Michaels EB, Hahn EC, Kenyon AJ.
    Am J Vet Res; 1983 Oct; 44(10):1977-83. PubMed ID: 6638657
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.